CoaguChek®: The Point of Care coagulation monitoring solution from Roche

Your trusted companion for anticoagulation care from the hospital to patients' homes.

Find your product Contact us
CoaguChek Vantus

Coagulation self-testing can reduce visits to the clinic and improve time in the therapeutic range1-5

Since 1992, CoaguChek® by Roche Diagnostics has led the way in Point of Care (POC) testing, developing innovative solutions in coagulation monitoring for both professionals and patients alike. As a market leader in POC International Normalized Ratio (INR) monitoring solutions, CoaguChek® has played a vital role in anticoagulation therapy, particularly for patients on Vitamin K Antagonist (VKA) medications such as warfarin.

Patient Self Testing of INR has emerged as a resounding success story. Studies have demonstrated that patients managed with POC testing achieve a higher time in therapeutic range and fewer values out of range compared with patients treated with usual care.1-3 This results in fewer treatment-related complications,4,5 fewer hospitalizations and emergency department visits,4,5 and improved patient satisfaction.6-8

Despite the advent of Direct Oral Anticoagulants (DOACs), which have become the preferred choice for many patients, there remains a crucial segment for whom DOACs are not suitable. For these patients, CoaguChek® continues to be the cost-effective and proven INR monitoring solution, ensuring reliable and personalized care.

An HCP is sitting in a clinic setting with a patient showing her a CoaguChek monitor

CoaguChek® solutions for the Point of Care

Performed by healthcare professionals immediately at the patient's point of care. CoaguChek® offers reliable and easy-to-use solutions that provide immediate results, allowing treatment decisions to be made promptly.

Featured products

The CoaguChek Vantus is designed with features to make accurate self-testing as easy and as repeatable as possible, including full-color display with easy-to-use on-screen instructions.
The CoaguChek® XS Pro system (CoaguChek XS Pro meter and CoaguChek XS PT Test strips) quantitatively determines prothrombin time (“PT”), using capillary blood or whole blood from a vein (nonanticoagulated venous whole blood). It is indicated for use by healthcare professionals. The system is ideally suited to monitor coagulation values in people who are taking oral anticoagulation medication (vitamin K antagonists, VKAs).
The CoaguChek® XS Plus system (CoaguChek XS Plus meter and CoaguChek XS PT Test strips) quantitatively determines prothrombin time (“PT”), using capillary blood or whole blood from a vein (nonanticoagulated venous whole blood). It is indicated for use by healthcare professionals. The system is ideally suited to monitor coagulation values in people who are taking oral anticoagulation medication (vitamin K antagonists, VKAs).
Find your product

References

  1. Harrison, et al. (2015). Anticoagulation management by community pharmacists. Int J Pharm Pract. 23, 173–181.
  2. Okuyama, et al. (2014). Introduction of POC testing in outpatient clinics and improvements in TTR. Circ J. 78, 1342–1348.
  3. Mearns, et al. (2014). Quality of vit K antagonist control and outcomes in atrial fibrillation patients. Thromb J, 12:14.
  4. Karlsson. (2016). A project to improve the management of patients on warfarin in primary care settings. BMJ Qual Improv Rep, 5, pii.w4421.
  5. Kong, et al. (2008). Feasibility, cost-effectiveness and patients' acceptance of POC INR testing. Ann Hematol. 87:905–910.
  6. Chan, et al. (2006). Management of patients on warfarin therapy in two models of anticoagulation service. Br J Clin Pharmacol, 62, 601–609.
  7. Thompson, et al. (2009). Evaluation of patient perceptions and outcomes related to anticoagulation POC testing in ambulatory care clinics. Pharm Pract (Granada), 7(4), 213–217.
  8. Wurster, & Doran. (2006). Anticoagulation management: a new approach. Dis Manag., 9(4), 201–209.